Humana Inc. (0J6Z.L)
USD 283.49
(-1.54%)
USD 283.49
(-1.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.51 Billion USD | -17.53% |
| 2022 | 6.69 Billion USD | -31.93% |
| 2021 | 9.83 Billion USD | 297.86% |
| 2020 | 2.47 Billion USD | 19.95% |
| 2019 | 2.06 Billion USD | -44.71% |
| 2018 | 3.72 Billion USD | 324.37% |
| 2017 | 878 Million USD | 308.37% |
| 2016 | 215 Million USD | -82.42% |
| 2015 | 1.22 Billion USD | -35.29% |
| 2014 | 1.89 Billion USD | 29.27% |
| 2013 | 1.46 Billion USD | 211.94% |
| 2012 | -1.3 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 6.26 Billion USD | -14.2% |
| 2024 Q3 | 7.9 Billion USD | 26.19% |
| 2024 Q1 | 7.3 Billion USD | -3.6% |
| 2023 Q4 | 7.57 Billion USD | 321.49% |
| 2023 Q3 | -3.42 Billion USD | 23.49% |
| 2023 Q2 | -4.47 Billion USD | -110.35% |
| 2023 FY | 7.57 Billion USD | 13.19% |
| 2023 Q1 | -2.12 Billion USD | -131.75% |
| 2022 Q4 | 6.69 Billion USD | 326.0% |
| 2022 Q2 | 7.67 Billion USD | -5.34% |
| 2022 Q1 | 8.11 Billion USD | -17.5% |
| 2022 FY | 6.69 Billion USD | -31.93% |
| 2022 Q3 | -2.96 Billion USD | -138.56% |
| 2021 Q2 | 3.79 Billion USD | 73.64% |
| 2021 FY | 9.83 Billion USD | 297.86% |
| 2021 Q4 | 9.83 Billion USD | 23.55% |
| 2021 Q3 | 7.95 Billion USD | 109.73% |
| 2021 Q1 | 2.18 Billion USD | 57.53% |
| 2020 Q1 | 3 Million USD | -99.67% |
| 2020 Q3 | -1.92 Billion USD | -74.3% |
| 2020 FY | 2.47 Billion USD | 19.95% |
| 2020 Q4 | 1.38 Billion USD | 172.01% |
| 2020 Q2 | -1.1 Billion USD | -36933.33% |
| 2019 Q4 | 913 Million USD | 663.58% |
| 2019 FY | 2.06 Billion USD | -44.71% |
| 2019 Q3 | -162 Million USD | 59.6% |
| 2019 Q2 | -401 Million USD | -180.36% |
| 2019 Q1 | 499 Million USD | -75.44% |
| 2018 Q2 | -3.27 Billion USD | 19.69% |
| 2018 Q1 | -4.08 Billion USD | -660.85% |
| 2018 FY | 3.72 Billion USD | 324.37% |
| 2018 Q3 | 632 Million USD | 119.27% |
| 2018 Q4 | 2.03 Billion USD | 221.52% |
| 2017 Q2 | -3.86 Billion USD | -5.9% |
| 2017 Q3 | -5.88 Billion USD | -52.54% |
| 2017 FY | 878 Million USD | 308.37% |
| 2017 Q4 | 728 Million USD | 112.36% |
| 2017 Q1 | -3.64 Billion USD | -4188.24% |
| 2016 Q4 | -85 Million USD | 97.14% |
| 2016 Q2 | 1.36 Billion USD | 37.5% |
| 2016 Q1 | 992 Million USD | -18.89% |
| 2016 Q3 | -2.97 Billion USD | -318.26% |
| 2016 FY | 215 Million USD | -82.42% |
| 2015 Q2 | 1.57 Billion USD | -16.24% |
| 2015 FY | 1.22 Billion USD | -35.29% |
| 2015 Q4 | 1.22 Billion USD | -45.03% |
| 2015 Q3 | 2.22 Billion USD | 41.45% |
| 2015 Q1 | 1.87 Billion USD | -0.63% |
| 2014 Q2 | 1 Billion USD | 7.05% |
| 2014 Q3 | 1.12 Billion USD | 11.88% |
| 2014 Q4 | 1.89 Billion USD | 68.6% |
| 2014 Q1 | 936 Million USD | -35.98% |
| 2014 FY | 1.89 Billion USD | 29.27% |
| 2013 FY | 1.46 Billion USD | 211.94% |
| 2013 Q1 | 1.21 Billion USD | 192.65% |
| 2013 Q2 | 1.08 Billion USD | -10.17% |
| 2013 Q3 | 1.34 Billion USD | 24.01% |
| 2013 Q4 | 1.46 Billion USD | 8.46% |
| 2012 Q3 | -1.36 Billion USD | 64.77% |
| 2012 Q4 | -1.3 Billion USD | 4.18% |
| 2012 Q2 | -3.86 Billion USD | 0.0% |
| 2012 FY | -1.3 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 7406.353% |
| Accuray Incorporated | 103.58 Million USD | -5227.94% |
| Align Technology, Inc. | -840.47 Million USD | 756.656% |
| Elevance Health Inc. | 18.59 Billion USD | 70.318% |
| AxoGen, Inc. | 32.26 Million USD | -17004.692% |
| Boston Scientific Corporation | 8.23 Billion USD | 32.957% |
| CVS Health Corporation | 71.18 Billion USD | 92.247% |
| Cardinal Health, Inc. | 476 Million USD | -1059.454% |
| Centene Corporation | 506 Million USD | -990.711% |
| DaVita Inc. | 10.65 Billion USD | 48.187% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 86.514% |
| Hologic, Inc. | 374.4 Million USD | -1374.092% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -1017.324% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -1.875% |
| Masimo Corporation | 804 Million USD | -586.443% |
| McKesson Corporation | 889 Million USD | -520.81% |
| Patterson Companies, Inc. | 648.47 Million USD | -751.07% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -17.852% |
| ResMed Inc. | 635.57 Million USD | -768.349% |
| Henry Schein, Inc. | 2.57 Billion USD | -114.747% |
| Teladoc Health, Inc. | 468.6 Million USD | -1077.759% |
| Universal Health Services, Inc. | 5.24 Billion USD | -5.18% |
| Veeva Systems Inc. | -647.71 Million USD | 952.076% |
| Baxter International Inc. | 11.16 Billion USD | 50.573% |
| Becton, Dickinson and Company | 14.46 Billion USD | 61.841% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 307.458% |
| Danaher Corporation | 13.49 Billion USD | 59.094% |
| Stryker Corporation | 10.02 Billion USD | 44.942% |
| Medtronic plc | 23.67 Billion USD | 76.692% |